LIPASE INHIBITORS FOR THE TREATMENT OF DYSPEPSIA

Title:

LIPASE INHIBITORS FOR THE TREATMENT OF DYSPEPSIA

Document Type and Number:

WIPO Patent Application WO2002011719

Kind Code:

A3

Abstract:

The present invention refers to the use of lipase inhibitors, e.g. orlistat, for the manufacture of medicaments for treating, reducing or preventing functional dyspepsia, e.g. intensity of stomach fullness, nausea, bloating after ingestion of small or larger meal, especially of fat containing or fat rich meals, and the medicaments thus manufactured.

More Like This:

WO/2004/078167	USE OF NON-IMMUNOSUPPRESSIVE PIPECOLIC ACID DERIVATIVES FOR INDUCING CHONDROGENIC DIFFERENTIATION
JP2001503774	[Title of Invention] 5-HT Lower 1F Agonist
WO/2001/021206	PREVENTIVES OR REMEDIES FOR MYOCARDITIS, DILATED CARDIOMYOPATHY AND CARDIAC INSUFFICIENCY CONTAINING NF-$g(k)B INHIBITORS AS THE ACTIVE INGREDIENT

Inventors:

FEINLE CHRISTINE
FRIED MICHAEL
LENGSFELD HANS
RADES THOMAS

Application Number:

PCT/EP2001/008776

Publication Date:

June 20, 2002

Filing Date:

July 28, 2001

Export Citation:

Click for automatic bibliography generation Help

Assignee:

HOFFMANN LA ROCHE (CH)

International Classes:

A61K31/00; A61K31/335; A61K45/00; A61K31/337; A61P1/14; A61P43/00; (IPC1-7): A61K31/337; A61P1/14

Foreign References:

US4598089A

1986-07-01

Other References:

DEGEN ET AL: "fat malabsorption and gut transit in healthy subjects: studies with orlistat a specific lipase inhibitor", GASTROENTEROLOGY, vol. 112, no. 4, 1997, pages a719, XP001055469
BAZALDUA ET AL: "evaluation and management of dyspepsia", AMERICAN FAMILY PHYSICIAN, vol. 60, no. 6, 1999, pages 17773 - 1784, XP001041051

Download PDF:

View/Download PDF PDF Help

Previous Patent: COSMETICS TO SUPPORT SKIN METABOLISM

Next Patent: SUBSTITUTED AND NON-SUBSTITUTED BENZOOXATHIAZOLES AND COMPOUNDS DERIVED THEREFROM